C. Babis Andreadis
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (NCT04545762) | C. Babis Andreadis | 2020-09-11 |
Track C. Babis Andreadis automatically
Every clearance here is in the API, with alerts when new ones post.